Clinical Trial Update: The AUS-PREDICT Registry for DCIS Patients With DCISionRT Testing

View source ↗

Summary

The AUS-PREDICT Registry is a study of DCIS patients who undergo DCISionRT testing, sponsored by PreludeDx. The registry is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ductal Carcinoma in Situ

Snippet

Sponsor: PreludeDx | Conditions: DCIS | Status: ACTIVE_NOT_RECRUITING